Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Beta Bionics Q2 EPS $(0.39) Beats $(0.47) Estimate, Sales $23.24M Beat $19.68M Estimate

Author: Benzinga Newsdesk | July 29, 2025 04:03pm
Beta Bionics (NASDAQ:BBNX) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.47) by 16.67 percent. The company reported quarterly sales of $23.24 million which beat the analyst consensus estimate of $19.68 million by 18.06 percent.

Posted In: BBNX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist